To more accurately reflect therapeutic potential, the authors also blocked the PD-1 signaling pathway (using an anti-PD-1 neutralizing antibody) during infection of WT mice, and found a 70% survival rate that persisted for at least 6 months, as compared to 0% survival seen in the untreated group. Here, PDCD1 is linked to infection.